Effect of cardiac lymph flow obstruction on cardiac collagen synthesis and interstitial fibrosis

Physiological Research

Volumn 55, Issue 3, 2006, Pages 253-258

  Kong, D ^a   Kong, X ^a   Wang, L ^b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Cardiac lymph flow; Collagen; mRNA; Rabbits

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXPERIMENTATION; FEMALE; HEART; HEART LYMPHATIC OBSTRUCTION; HEART MUSCLE FIBROSIS; LYMPH FLOW; LYMPHATIC SYSTEM DISEASE; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; CARDIAC SURGICAL PROCEDURES; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; EDEMA, CARDIAC; FEMALE; FIBROSIS; GENE EXPRESSION; HEART RATE; IN SITU HYBRIDIZATION; LIGATION; LYMPHATIC DISEASES; LYMPHATIC VESSELS; MALE; MYOCARDIUM; PEPTIDE FRAGMENTS; PROCOLLAGEN; RABBITS; RNA, MESSENGER; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 33745220991     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. DÍEZ J, LAVIADES C, MAYOR G, GIL MJ, MONREAL I: Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation 91: 1450-1456, 1995.
2. LAINE GA, ALLEN SJ: Left ventricular myocardial edema: lymph flow, interstitial fibrosis, and cardiac function. Circ Res 68: 1713-1721, 1991.
3. MCKINNEY B: Endocardial changes produced in Patus monkeys by the ablation of cardiac lymphatics and the administration of a plantain diet. Am Heart J 91: 484-491, 1976.
4. MILLER A: Pathology of interference with cardiac lymph flow. In: Lymphatics of the Heart. Raven Press, New York, 1982, pp 262-334.
5. MILLER AJ: The study of the lymphatics of the heart: an overview. Microcirc Endothelium Lymphatics 2: 349-360, 1985.
6. MILLER AJ, PICK R, KATZ LN: Ventricular endomyocardial pathology produced by chronic cardiac lymphatic obstruction in the dog. Circ Res 8: 941-947, 1960.
7. MILLER A, PICK R, KATZ LN: Ventricular endomyocardial changes after impairment of cardiac lymph flow in dogs. Br Heart J 25: 182, 1963.
8. QUEREJETA R, LOPEZ B, GONZALEZ A, SANCHEZ E, LARMAN M, MARTINEZ UBAGO JL, DIEZ J: Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110: 1263-1268, 2004.
9. RILEY D, GULLO J: Pressure applied to cultured pulmonary artery endothelial cells causes release of a fibroblast mitogen and induces a proto-oncogene (abstract). FASEB J 2: A300, 1988.
10. SUN SC, LIE JT: Cardiac lymphatic obstruction: ultrastructure of acute-phase myocardial injury in dogs. Mayo Clinic Proc 52: 785-792, 1977.
11. ULLAL SR. KLUGE TH, GERBODE F: Functional and pathologic changes in the heart following chronic cardiac lymphatic obstruction. Surgery 71: 328-334, 1972.
12. WITTE CL, WITTE MH, DUMONT AE: Pathophysiology of chronic edema, lymphedema, and fibrosis. In: Edema. NC STAUB, AE TAYLOR (eds), Raven Press, New York, 1984, pp 521-42.